C. James Chou, Ph.D. Graduated from the University of Washington with a double diploma (B.S. and B.A.) in Biochemistry and Economics with a Ph.D. in Chemistry, Dr. Chou has long been interested in studying biological processes through the development of new chemical tools, particularly in the area of gene transcription regulation and mitochondrial biology. For the last 15 years, Dr. Chou has been involved in multiple projects encompassing the development of therapeutics for cancer, Friedreich's ataxia, epilepsy, and mitochondrial DNA depletion syndrome.
Sherine Chan, Ph.D. BSc (Hons) Murdoch University, PhD University of Western Australia Dr. Chan and Dr. Chou co-founded Neuroene Therapeutics in 2015. Dr. Chan is also an Associate Professor of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina, with expertise in mitochondrial dysfunction and mitochondrial diseases. Her group has created new zebrafish models, which are being used to identify new biomarkers for diseases of mitochondrial origin and to identify new therapeutics for mitochondrial diseases.